Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cardinal Health Inc (CAH) vs Uber Technologies Inc (UBER) Price & Performance

Cardinal Health IncTrade
Uber Technologies IncTrade

Price performance (Past 24H)

Key statistics

Cardinal Health Inc vs Uber Technologies Inc — how do they compare? Cardinal Health Inc trades at $228.31 (market cap $53.89B), while Uber Technologies Inc trades at $72.63 (market cap $146.73B). The key difference: Uber Technologies Inc is far larger — about 2.7× Cardinal Health Inc's market cap, and Cardinal Health Inc pays a 0.89% dividend while Uber Technologies Inc pays none. Which is the better fit depends on your goals.

CAHUBER
Market Cap
$53.89B$146.73B
Sector
HealthIndustrials
52-Week High
$239.71$100.10
52-Week Low
$146.04$68.61
Enterprise Value
$58.87B$153.05B
Dividend Yield
0.89%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cardinal Health Inc

Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.

The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.

Uber Technologies Inc

Uber Technologies (UBER) trades at $74.26, down 0.38% on the day, with strong analyst consensus of 49 buys and 0 sells. The stock shows bullish technical signals with moving averages supporting upward momentum. Fundamentally, Uber demonstrates robust revenue growth from $31.9B in 2022 to $52.0B in 2025, though net income margin has moderated from 22.41% to 19.32%. Recent developments include strategic moves into autonomous vehicles with partnerships in Spain and Germany.

Uber presents a compelling growth story with expanding profitability and dominant market position. The 36% upside to consensus price target of $108.92 suggests significant potential. Key risks include execution challenges in autonomous vehicle rollout, competitive pressures in key markets like India, and potential margin compression. Operating cash flow strength at $10.1B supports continued investment in growth initiatives.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Cardinal Health Inc

Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Read more on CAH

About Uber Technologies Inc

Uber Technologies is a technology provider that matches riders with drivers, hungry people with restaurants and food delivery service providers, and shippers with carriers. The firm's on-demand technology platform could eventually be used for additional products and services, such as autonomous vehicles, delivery via drones, and Uber Elevate, which, as the firm refers to it, provides aerial ride-sharing. Uber Technologies is headquartered in San Francisco and operates in over 63 countries with over 110 million users that order rides or foods at least once a month. Approximately 76% of its gross revenue comes from ride-sharing and 22% from food delivery.

Read more on UBER